ABVIDA M 50/500 TABLET

Abvida-M 50 mg/500 mg Tablet is a combination drug of Vildagliptin (DPP-4 inhibitor) and Metformin (Biguanides) belongs to the class of anti-diabetic. Type 2 diabetes mellitus used to be known as ‘non-insulin-dependent diabetes mellitus (NIDDM)’ or ‘maturity-onset diabetes. Type 2 diabetes develops if the body does not produce enough insulin or when your body’s insulin does not work as well as it should. It can also develop if the body produces too much glucagon. Insulin is a substance which helps to lower the level of sugar in your blood, especially after meals. Abvida-M 50 mg/500 mg Tablet is another substance which triggers the production of sugar by the liver, causing the blood sugar to rise. The pancreas makes both of these substances.

Abvida-M 50 mg/500 mg Tablet helps to control the blood sugar level. It works by making the pancreas produce insulin and less glucagon (effect of vildagliptin) and also by helping the body to make better use of the insulin it has (effect of metformin). You must continue following the diet and exercise recommended for you whilst on treatment with Abvida-M 50 mg/500 mg Tablet . Abvida-M 50 mg/500 mg Tablet is not a substitute for insulin. It is not used to treat type 1 diabetes (where your body does not produce insulin) or diabetic ketoacidosis.

Abvida-M 50 mg/500 mg Tablet should be taken with food to avoid an upset stomach. Abvida-M 50 mg/500 mg Tablet should be taken at the same time of the day each time for best results. For better advice, your doctor will decide what dose should be taken, which can change quickly depending on your condition. The most common side effect of Abvida-M 50 mg/500 mg Tablet is hypoglycemia (low blood glucose levels) characterised by dizziness, sweating, palpitations, hunger pangs, dry mouth and skin etc. So, to avoid hypoglycemia, you should not miss meals and also should carry some form of sugar along with you. Other side effects include taste change, nausea, diarrhoea, stomach pain, headache, and upper respiratory symptoms.

Abvida-M 50 mg/500 mg Tablet should not be stopped even if you feel better without consulting your doctor as sugar levels change. If you stop taking Abvida-M 50 mg/500 mg Tablet abruptly, it may increase your sugar levels which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy) and nerve damage (neuropathy). Abvida-M 50 mg/500 mg Tablet should not be taken if you have type 1 diabetes mellitus or severe kidney or liver disease. Please inform your doctor if you have any heart disease or planning to get pregnant or breastfeed.

Treatment of Type 2 Diabetes Mellitus

Abvida-M 50 mg/500 mg Tablet helps your pancreas produce more insulin, effectively utilise insulin, and decrease the excess sugar that your liver makes. It helps control the rise of blood sugar levels in your body after a meal. Abvida-M 50 mg/500 mg Tablet plays a vital role in controlling blood sugar levels and prevents serious complications of diabetes like eyesight loss (retinopathy), kidney (nephropathy), nerve damage (neuropathy), diabetic foot ulcer and delayed wound healing.

Swallow it as a whole with water; do not crush, break or chew it.

Store in a cool and dry place away from sunlight

• Low blood sugar
• Nausea
• Headache
• Shaking or quivering
• Vomiting
• Diarrhoea
• Abdominal pain
• Loss of appetite
• Joint pain
• Tiredness
• Constipation
• Swollen hands
• Ankle or feet (oedema)